D2 and D1 dopaminergic activity of 7-OH-DPAT

Brain Research

Volumn 733, Issue 1, 1996, Pages 41-45

  Sethy, Vimala H ^a   Ellerbrock, Brenda R ^a   Fici, Greg J ^a   Wu, Haiyan ^a  

^a PFIZER INC   (United States)

Author keywords

7 OH DPAT; Acetylcholine, striatal; Cyclic AMP; D1 D2 dopamine activity

Indexed keywords

2 DIPROPYLAMINO 5,6 DIMETHOXYINDAN; 2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACETYLCHOLINE; CYCLIC AMP; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; QUINPIROLE; RACLOPRIDE; UNCLASSIFIED DRUG; (5,6 DIMETHOXYINDAN 2 YL)DIPROPYLAMINE; (5,6-DIMETHOXYINDAN-2-YL)DIPROPYLAMINE; 7 HYDROXY 2 N,N DIPROPYLAMINOTETRALIN; 7-HYDROXY-2-N,N-DIPROPYLAMINOTETRALIN; INDAN DERIVATIVE; TETRALIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; GRANULE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; NEOSTRIATUM; SPRAGUE DAWLEY RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ACETYLCHOLINE; ANIMALS; CELLS, CULTURED; CEREBELLUM; CYCLIC AMP; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; HALOPERIDOL; INDANS; MALE; NEOSTRIATUM; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; TETRAHYDRONAPHTHALENES;

EID: 85047677279     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00531-8     Document Type: Article

References (27)

1. 3 receptor-selective ligand, 7-OH-DPAT, in the normal and reserpine-treated rat, Eur. J. Pharmacol., 260 (1994) 177-181.
2. [2] Bloom, F.F., Costa, E. and Salmoiraghi, G.C., Anesthesia and the responsiveness of individual neurons of the caudate nucleus of the cat to acetylcholine, norepinephrine and dopamine administered by microelectrophoresis. J. Pharmacol. Exp. Ther., 150 (1965) 244-252.
3. [3] Bowery, B., Rothwell, L.A. and Seabrook, G.R., Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through substantia nigra pars compacta and ventral tegmental area, Br. J. Pharmacol., 112 (1994) 873-880.
4. [4] Daly, S.A. and Waddington, J.L., Behavioral effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other 'D-2 like' agonists, Neuropharmacology, 32 (1993) 509-510.
5. [5] Damsma, G., Bottema, T., Westerink, B.H.C., Tepper, P.G., et al., Pharmacological aspects of R(+)-7-OH-DPAT, a putative dopamine D3 receptor ligand. Eur. J. Pharmacol., 249 (1993) R9-R10.
6. 1 dopamine receptor in the rat brain: Quantitative autoradiographic localization using iodinated ligand. Neuroscience, 26 (1988) 83-100.
7. 1 dopamine receptor activity of antiparkinson drugs, Soc. Neurosci. Abstr., 21 (1995) 1254.
8. [8] Ikai, Y., Takada, M., Shinonaga, Y. and Mizuno, N., Dopaminergic and non-dopamingeric neurons in the ventral tegmental area of the rat project, respectively, to the cerebellum cortex and deep cerebellar nuclei, Neuroscience, 51 (1992) 719-728.
9. 3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography, Eur. J. Neurosci., 5 (1993) 145-153.
10. 3H)-hydroxy-N,N-di-n-propyl-2-aminotetralin, Proc. Natl. Acad. Sci. USA, 89 (1992) 8155-8159.
11. [11] Liu, J., Cox, R.F., Greif, G.J., Freeman, J.E. and Waszczak, B., The putative dopamine D3 receptor agonist 7-OH-DPAT: Lack of mesolimbic selectivity, Eur. J. Pharmacol., 264 (1994) 269-278.
12. 1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques, Neuroscience, 45 (1991) 359-371.
13. [13] McLennan, H. and York, D.H., The action of dopamine neurons of caudate nucleus, J. Physiol. (Lond.), 189 (1967) 393-402.
14. [14] Meador-Woodruff, J.H., Neuroanatomy of dopamine gene expression: Potential substrate for neuropsychiatric illness, Clin. Neuropharmacol., 18 (Suppl. 1) (1995) 514-524.
15. 1 receptor mRNA in human and rat brain, Brain Res. Mol. Brain Res., 10 (1991) 185-191.
16. [16] Nicoletti, F., Wroblewski, J.T., Novelli, A., Alho, H., Guidotti, A. and Costa, E., The activation of inositol phospholipid metabolism as a signal-transducing system for excitatory amino acids in primary cultures of cerebellar granule cells, J. Neurosci., 6 (1986) 1905-1911.
17. [17] Novelli, A., Reilly, J.A., Lysko, P.G. and Henneberry, R.C., Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced, Brain Res., 451 (1988) 205-212.
18. [18] Scatton, B., Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: Evidence against dopamine receptor multiplicity, J. Pharmacol. Exp. Ther., 220 (1982) 197-202.
19. 2 dopamine receptors, Eur. J. Pharmacol., 60 (1979) 397-398.
20. [20] Sethy, V.H., Ellerbrock, B.R. and Wu, H., Comparative dopaminergic and muscarinic antagonist activity of clozapine and haloperidol, Life Sci., 58 (1996) 585-590.
21. [21] Sethy, V.H. and Van Woert, M.H., Effect of L-dopa on brain acetylcholine and choline in rats, Neuropharmacology, 12 (1973) 27-31.
22. [22] Sethy, V.H. and Van Woert, M.H., Regulation of striatal acetylcholine concentration by dopamine receptors, Nature, 251 (1974) 529-530.
23. 3) as a target for neuroleptics, Nature, 347 (1990) 146-151.
24. [24] Svensson, K., Carlsson, A. and Waters, N., Locomotor inhibition by D3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release, J. Neural Transm., 95 (1994) 71-74.
25. 4 receptor with high affinity for the antipsychotic clozapine, Nature, 350 (1991) 610-614.
26. [26] Waters, N., Svensson, K., Haadsma-Svensson, S.R., Smith, M.W. and Carlsson A., The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity, J. Neural Transm., 94 (1993) 11-19.
27. [27] Wooley, D.F., A possible role for biogenic amine in presynaptic inhibition, Physiologist, 12 (1970) 399.